FDA Drug Recalls

Recalls / Class II

Class IID-0852-2022

Product

Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90.

Brand name
Pantoprazole Sodium
Generic name
Pantoprazole Sodium
Active ingredient
Pantoprazole Sodium
Route
Oral
NDCs
13668-096, 13668-429
FDA application
ANDA090074
Affected lot / code info
Lot #s: BA34G021, BA34G022, Exp. 09/2022

Why it was recalled

CGMP deviations: tablets cracking

Recalling firm

Firm
Torrent Pharma Inc
Manufacturer
Torrent Pharmaceuticals Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2091 Hartel Ave, N/A, Levittown, Pennsylvania 19057-4506

Distribution

Quantity
24,888 bottles
Distribution pattern
Nationwide in the U.S.A

Timeline

Recall initiated
2022-04-11
FDA classified
2022-05-05
Posted by FDA
2022-05-11
Terminated
2023-07-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0852-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Pantoprazole Sodium · FDA Drug Recalls